<- Go Home
OpGen, Inc.
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
Market Cap
$14.4M
Volume
129.1K
Cash and Equivalents
$1.6M
EBITDA
-$5.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$323.9K
Profit Margin
25.59%
52 Week High
$9.90
52 Week Low
$1.40
Dividend
N/A
Price / Book Value
4.82
Price / Earnings
-0.35
Price / Tangible Book Value
4.82
Enterprise Value
$14.8M
Enterprise Value / EBITDA
-2.79
Operating Income
-$6.0M
Return on Equity
331.94%
Return on Assets
-31.63
Cash and Short Term Investments
$1.6M
Debt
$2.1M
Equity
$3.0M
Revenue
$1.3M
Unlevered FCF
-$3.7M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium